Heather H. Cheng, MD, PhD

Dr. Heather Cheng focuses on improving the care of patients with prostate cancer. An expert in prostate cancer genetics, she is studying ways to use genetics to guide the care of prostate cancer patients and their family members who may also be at high risk for the disease. Dr. Cheng leads clinical trials of a variety of new treatments for prostate cancer. She is also developing new tests that could help guide doctors’ choice of treatment for each patient and new blood tests to detect and monitor the progression of prostate cancer.

Dr. Cheng has served in numerous national roles, including as a member of the Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic and Prostate guidelines panel and the Prostate Cancer guidelines panel of the National Comprehensive Cancer Network. She is the founding co-chair of the Prostate Cancer Clinical Trials Consortium Germline Genetics Working Group; a member of the American Society of Clinical Oncology education and guidelines committees for genetics and genomics, the American Urological Association, the American Cancer Society and the National Cancer Institute Genitourinary Cancers Steering Committee Task Force. Cheng serves as chief scientific advisor to the BRCA Research and Cure Alliance.